Medreleaf Corp. has acquired MED Colombia SAS, a company with licences in Colombia to cultivate cannabis and produce cannabis oil extracts (along with a library of cannabis genetics), for a total consideration of 2.75 million euros in cash. This acquisition provides Medreleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain, as well as the domestic Colombian medical cannabis market.
Read more
MEDRELEAF ACQUIRES MED COLOMBIA
